Zimmer Biomet’s Robotics and Smart Knee Push Might Change The Case For Investing In ZBH

Simply Wall St.03-01

Zimmer Biomet Holdings recently showcased new clinical and operational data alongside its “Magnificent Seven” orthopedic innovations, including advanced robotics, AI-driven navigation, and the Persona...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2616584365?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638","is_english":true,"pubTime":"2026-03-01 01:30","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2616584365","market":"us","top_or_hot":-1,"title":"Zimmer Biomet’s Robotics and Smart Knee Push Might Change The Case For Investing In ZBH","media":"Simply Wall St.","content":"<div>\n<p>Zimmer Biomet Holdings recently showcased new clinical and operational data alongside its “Magnificent Seven” orthopedic innovations, including advanced robotics, AI-driven navigation, and the Persona...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nyse-zbh/zimmer-biomet-holdings/news/zimmer-biomets-robotics-and-smart-knee-push-might-change-the\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Zimmer Biomet’s Robotics and Smart Knee Push Might Change The Case For Investing In ZBH</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nZimmer Biomet’s Robotics and Smart Knee Push Might Change The Case For Investing In ZBH\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-03-01 01:30 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/healthcare/nyse-zbh/zimmer-biomet-holdings/news/zimmer-biomets-robotics-and-smart-knee-push-might-change-the><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Zimmer Biomet Holdings recently showcased new clinical and operational data alongside its “Magnificent Seven” orthopedic innovations, including advanced robotics, AI-driven navigation, and the Persona...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nyse-zbh/zimmer-biomet-holdings/news/zimmer-biomets-robotics-and-smart-knee-push-might-change-the\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU0792757196.USD","symbol_name":"TEMPLETON SHARIAH GLOBAL EQUITY FUND \"A\" (USD) ACC","start_time":0,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-zbh/zimmer-biomet-holdings/news/zimmer-biomets-robotics-and-smart-knee-push-might-change-the","article_id":"2616584365","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-zbh/zimmer-biomet-holdings/news/zimmer-biomets-robotics-and-smart-knee-push-might-change-the","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2616584365","pubTimestamp":1772299808,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"Zimmer Biomet Holdings recently showcased new clinical and operational data alongside its “Magnificent Seven” orthopedic innovations, including advanced robotics, AI-driven navigation, and the Persona IQ smart knee implant, at the AAOS 2026 Annual Meeting.\nAn interesting angle for investors is how Zimmer Biomet is pairing traditional implant franchises like the Oxford Cementless Partial Knee with emerging smart and robotic systems to deepen its integrated orthopedic ecosystem.\nWe’ll now...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU0792757196.USD":"TEMPLETON SHARIAH GLOBAL EQUITY FUND \"A\" (USD) ACC","LU0211327993.USD":"TEMPLETON GLOBAL EQUITY INCOME \"A\" (USD) ACC","BK4585":"ETF&股票定投概念","LU0980610538.SGD":"Natixis Harris Associates US Equity RA SGD-H","ZBH":"齐默巴奥米特控股","BK4566":"资本集团","LU0310800379.SGD":"FTIF - Templeton Global A Acc SGD","LU1201861249.SGD":"Natixis Harris Associates US Equity PA SGD-H","LU1267930573.SGD":"TEMPLETON GLOBAL \"AA\" (SGD) ACC A","LU0889566641.SGD":"FTSF - Templeton Shariah Global Equity A Acc SGD","LU0130102774.USD":"Natixis Harris Associates US Equity RA USD","LU0310799852.SGD":"FTIF - Templeton Global Equity Income A MDIS SGD","BK4504":"桥水持仓","LU0006061336.USD":"Blackrock US Small and MidCap Opportunities A2 USD","LU1267930490.SGD":"TEMPLETON GLOBAL EQUITY INCOME \"AS\" (SGD) INC A","IE00B19Z3581.USD":"Legg Mason ClearBridge - Value A Acc USD","LU1267930813.SGD":"FRANKLIN TEMPLETON SHARIAH GLOBAL EQUITY \"AS\" (SGD) ACC","BK4588":"碎股","LU0708994859.HKD":"TEMPLETON GLOBAL \"A\" (HKD) ACC","BK4082":"医疗保健设备","LU0130517989.USD":"HARRIS ASSOCIATES US VALUE EQUITY \"R\" INC","LU0211328371.USD":"TEMPLETON GLOBAL EQUITY INCOME \"A\" (MDIS) (USD)   INC","IE00B19Z3B42.SGD":"Legg Mason ClearBridge - Value A Acc SGD","LU0029864427.USD":"TEMPLETON GLOBAL \"A\" (USD) INC","IE00B7SZLL34.SGD":"Legg Mason ClearBridge - Value A Acc SGD-H","LU0648001328.SGD":"Natixis Harris Associates US Equity RA SGD","LU0128525929.USD":"TEMPLETON GLOBAL \"A\" (USD) ACC","IE0002270589.USD":"LEGG MASON CLEARBRIDGE VALUE \"A\" (USD) INC","LU0477156953.USD":"HARRIS ASSOCIATES US VALUE EQUITY \"RE\" (USD) ACC"},"translate_title":"Zimmer Biomet的机器人和智能膝盖推动可能会改变投资ZBH的理由","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ZBH":1.5},"content_text":"Zimmer Biomet Holdings recently showcased new clinical and operational data alongside its “Magnificent Seven” orthopedic innovations, including advanced robotics, AI-driven navigation, and the Persona IQ smart knee implant, at the AAOS 2026 Annual Meeting. An interesting angle for investors is how Zimmer Biomet is pairing traditional implant franchises like the Oxford Cementless Partial Knee with emerging smart and robotic systems to deepen its integrated orthopedic ecosystem. We’ll now examine how the expanded ROSA and broader orthopedic robotics suite at AAOS could influence Zimmer Biomet’s investment narrative. This technology could replace computers: discover 22 stocks that are working to make quantum computing a reality.AdvertisementZimmer Biomet Holdings Investment Narrative RecapTo own Zimmer Biomet, you need to believe that robotics, AI-enabled navigation and connected implants can reinforce its core joint portfolio rather than disrupt it. The AAOS 2026 showcase underlines this integrated ecosystem story, but it does not fundamentally change the near term tension between monetizing premium robotic platforms and the key risk of competitors pushing hard on autonomous systems and hospital pricing, which could still pressure margins and limit how quickly these innovations translate into financial results. Among recent announcements, the expanded ROSA Knee with OptimiZe is most directly tied to this AAOS news, because it sits at the center of Zimmer Biomet’s robotics push. The system’s focus on more personalized planning and automated alignment fits the broader catalyst of moving surgeons toward higher value digital procedures, while also highlighting the execution risk that rivals such as Stryker could outpace Zimmer Biomet in advanced robotic capabilities if adoption or regulatory milestones slip. Yet even with this robotics momentum, investors should be aware that rising competitive intensity in orthopedic robotics could... Read the full narrative on Zimmer Biomet Holdings (it's free!)Zimmer Biomet Holdings' narrative projects $9.2 billion revenue and $1.3 billion earnings by 2028. This requires 5.5% yearly revenue growth and a roughly $0.5 billion earnings increase from $823.5 million today.Uncover how Zimmer Biomet Holdings' forecasts yield a $102.65 fair value, a 4% upside to its current price.Exploring Other PerspectivesZBH 1-Year Stock Price Chart Four fair value estimates from the Simply Wall St Community span roughly US$95 to about US$172, reflecting a wide spread in expectations. You should weigh this dispersion against the central catalyst that Zimmer Biomet’s push into robotics and smart implants depends on successful commercialization in a market facing pricing pressure and strong competitors, which could shape how quickly any perceived mispricing closes.Explore 4 other fair value estimates on Zimmer Biomet Holdings - why the stock might be worth as much as 75% more than the current price!Reach Your Own ConclusionDon't just follow the ticker - dig into the data and build a conviction that's truly your own.A great starting point for your Zimmer Biomet Holdings research is our analysis highlighting 3 key rewards and 2 important warning signs that could impact your investment decision.Our free Zimmer Biomet Holdings research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Zimmer Biomet Holdings' overall financial health at a glance.Ready To Venture Into Other Investment Styles?Opportunities like this don't last. These are today's most promising picks. Check them out now:Find 46 companies with promising cash flow potential yet trading below their fair value.We've uncovered the 15 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.AI is about to change healthcare. These 27 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.  This article by Simply Wall St is general in nature. We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.Valuation is complex, but we're here to simplify it.Discover if Zimmer Biomet Holdings might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2616584365","isCrawlerRequest":true}